Zhu BD, Yuan SJ, Zhao QC, Li X, Li Y, Lu QY. Antitumor effect of Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma. World J Gastroenterol 2005; 11(9): 1382-1386 [PMID: 15761981 DOI: 10.3748/wjg.v11.i9.1382]
Corresponding Author of This Article
Dr. Bu-Dong Zhu, Department of Medical Oncology, Peking University School of Oncology and Beijing Institute for Cancer Research, Beijing Cancer Hospital, Beijing 100036, China. zhubd@tom.com.cn
Article-Type of This Article
Brief Reports
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/